台股 » 個股 » 生華科 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

生華科

(6492)
可現股當沖
  • 股價
    41.30
  • 漲跌
    ▲0.60
  • 漲幅
    +1.47%
  • 成交量
    122
  • 產業
    上櫃 生技醫療類股
  • 147人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
生華科 (6492)籌碼相關-富邦-八德 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

富邦-八德 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/04/2400.00440.9041.10-4183-2.18%
2024/04/15043.5000.0042.3001870.00%
2024/04/09043.9000.0043.5501910.00%
2024/04/0200.00643.6743.95-6192-3.12%
2024/03/28044.3000.0043.4001990.00%
2024/03/18142.5000.0042.2511990.50%
2024/03/06043.9500.0043.4003310.00%
2024/03/05243.7800.0043.8023350.60%
2024/02/2200.00345.3245.25-3398-0.75%
2024/02/1500.000.246.0046.00-0.2436-0.05%
2024/01/3000.00146.8546.75-1595-0.17%
2024/01/2500.000.547.9547.35-0.5766-0.07%
2024/01/1900.00346.6746.65-31,277-0.23%
2024/01/1800.00146.7046.65-11,307-0.08%
2024/01/1700.00346.3046.25-31,309-0.23%
2024/01/09148.5000.0048.2511,3250.08%
2023/12/29150.9000.0050.9011,3080.08%
2023/12/26252.10151.9051.8011,3030.08%
2023/12/25151.2000.0050.9011,2950.08%
2023/12/18153.8000.0053.2011,2810.08%
2023/12/1500.00352.9053.50-31,277-0.23%
2023/12/14153.5000.0053.4011,2740.08%
2023/12/0600.00455.4054.60-41,250-0.32%
2023/12/05156.5000.0055.8011,2370.08%
2023/12/04660.15256.9060.7041,1970.33%
2023/12/01455.50156.2055.3031,1370.26%
2023/11/300.554.8000.0054.200.51,1240.04%
2023/11/28154.90254.9055.00-11,119-0.09%
2023/11/27355.80255.9055.2011,1190.09%
2023/11/2400.00254.6054.30-21,097-0.18%
2023/11/23355.30455.5055.40-11,099-0.09%
2023/11/22755.49154.8054.8061,0960.55%
2023/11/1500.00154.9054.00-11,042-0.10%
2023/11/14153.5000.0054.8011,0330.10%
2023/11/10256.75554.9654.10-31,010-0.30%
2023/11/09153.2000.0053.4019480.11%
2023/11/08157.40155.9055.4009290.00%
2023/11/07158.80157.8057.8009040.00%
2023/11/06258.80357.7757.40-1861-0.12%
2023/11/03561.16560.9059.4008120.00%
2023/11/023.959.27258.4059.101.97440.26%
2023/11/011059.80960.0460.4016900.14%
2023/10/311257.93858.6458.8045060.79%
2023/10/30157.4000.0054.5013690.27%
2023/10/2700.00154.4054.40-1240-0.42%
2023/10/26247.10247.8549.5001830.00%
2023/10/2400.00145.4045.20-1152-0.66%
2023/10/23246.5300.0046.4521491.34%
2023/10/200.544.4000.0044.300.51380.36%
2023/10/1600.00143.2043.35-1132-0.76%
2023/10/1200.00144.0544.05-1141-0.71%
2023/09/05245.50145.7045.7011570.63%
2023/09/010.246.5000.0046.300.21530.13%
2023/08/14141.1000.0041.0011310.76%
2023/08/0700.00142.9042.65-1127-0.79%
2023/07/1000.00049.1049.6501260.00%
2023/07/07149.2500.0049.1011270.79%
2023/06/2600.000.249.6049.55-0.2130-0.12%
2023/06/020.152.4000.0051.800.11380.07%
2023/05/240.252.70152.7052.90-0.9154-0.55%
2023/05/23150.2000.0054.0011540.65%
2023/05/2200.000.249.9049.85-0.2150-0.10%
2023/05/1700.000.248.9049.40-0.2156-0.13%
2023/05/1200.000.348.7049.15-0.3167-0.18%
2023/04/24053.8000.0051.6001810.00%
2023/04/21055.8000.0051.9001820.00%
2023/04/1900.00154.4054.50-1180-0.55%
2023/04/18254.8000.0054.5021801.11%
上櫃「肥貓」董監現形 台嘉碩、大宇資、穩懋、生華科為前四肥Anue鉅亨-14天前
生華科治療新冠、流感等泛病毒感染新藥 將啟動二期臨床Anue鉅亨-2023/11/21
生華科泛病毒感染肺炎新藥 向美申請二期臨床Anue鉅亨-2023/10/19
生華科 相關文章
生華科 相關影音